Glucagon-like peptide-1: Difference between revisions
No edit summary |
|||
(6 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
{{ | {{SK}} GLP-1 | ||
==Overview== | ==Overview== | ||
Line 11: | Line 10: | ||
GLP-1 secretion by L cells is dependent on the presence of nutrients in the lumen of the small intestine. The [[secretagogue|secretagogues]] (agents that causes or stimulates secretion) of this hormone include major nutrients like [[carbohydrate]], [[protein]] and [[lipid]]. Once in the circulation, GLP-1 has a half life of less than 2 minutes, due to rapid degradation by the enzyme [[dipeptidyl peptidase-4]]. | GLP-1 secretion by L cells is dependent on the presence of nutrients in the lumen of the small intestine. The [[secretagogue|secretagogues]] (agents that causes or stimulates secretion) of this hormone include major nutrients like [[carbohydrate]], [[protein]] and [[lipid]]. Once in the circulation, GLP-1 has a half life of less than 2 minutes, due to rapid degradation by the enzyme [[dipeptidyl peptidase-4]]. | ||
[[Image:Incretins_and_DPP_4_inhibitors.png|thumb|350px|left|GLP-1 and DPP-4 inhibitors]] | |||
<br clear="left"/> | |||
==Physiological functions== | ==Physiological functions== | ||
Line 22: | Line 23: | ||
==See also== | ==See also== | ||
* [[Glucagon-like peptide-1 analog]] | |||
* [[Glucagon-like peptide 1 receptor]] | * [[Glucagon-like peptide 1 receptor]] | ||
* [[Glucagon-like peptide-2]] | * [[Glucagon-like peptide-2]] | ||
Line 29: | Line 31: | ||
==References== | ==References== | ||
{{Reflist|2}} | |||
{{Proglucagon}} | {{Proglucagon}} | ||
{{Oral hypoglycemics}} | {{Oral hypoglycemics}} | ||
[[Category:Diabetes]] | [[Category:Diabetes]] | ||
[[Category:Hormones]] | [[Category:Hormones]] |
Latest revision as of 18:12, 28 July 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: GLP-1
Overview
Glucagon-like peptide-1 (GLP-1) is derived from the transcription product of the proglucagon gene. The major source of GLP-1 in the body is the intestinal L cell that secretes GLP-1 as a gut hormone. The biologically active forms of GLP-1 are: GLP-1-(7-37) and GLP-1-(7-36)NH2.
GLP-1 secretion by L cells is dependent on the presence of nutrients in the lumen of the small intestine. The secretagogues (agents that causes or stimulates secretion) of this hormone include major nutrients like carbohydrate, protein and lipid. Once in the circulation, GLP-1 has a half life of less than 2 minutes, due to rapid degradation by the enzyme dipeptidyl peptidase-4.
Physiological functions
GLP-1 possesses several physiological properties that make it a subject of intensive investigation as a potential treatment of diabetes mellitus.[1][2][3]. The known physiological functions of GLP-1 include:
- increases insulin secretion from the pancreas in a glucose-dependent manner.
- decreases glucagon secretion from the pancreas.
- increases beta cells mass and insulin gene expression.
- inhibits acid secretion and gastric emptying in the stomach.
- decreases food intake by increasing satiety.
See also
- Glucagon-like peptide-1 analog
- Glucagon-like peptide 1 receptor
- Glucagon-like peptide-2
- type 2 diabetes
- exenatide
- Dipeptidyl peptidase-4
References
- ↑ "Diabetes and Intestinal Incretin Hormones: A New Therapeutic Paradigm" at medscape.com (slide 36)
- ↑ Toft-Nielsen M, Madsbad S, Holst J (2001). "Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes". J Clin Endocrinol Metab. 86 (8): 3853–60. PMID 11502823.
- ↑ Meier J, Weyhe D, Michaely M, Senkal M, Zumtobel V, Nauck M, Holst J, Schmidt W, Gallwitz B (2004). "Intravenous glucagon-like peptide 1 normalizes blood glucose after major surgery in patients with type 2 diabetes". Crit Care Med. 32 (3): 848–51. PMID 15090972.